Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: Beltropolis Boy who wrote (849)	1/14/1999 8:21:00 AM
From: Harold Engstrom	Read Replies (1) \| Respond to of 1686

Chris, thanks for the Intron A article. Funny comment: ''It doesn't seem like it's worth it,'' said To, who has an ''accumulate'' recommendation on Biogen shares. ''They could lose and really hurt their relationship with Schering-Plough.'' I doubt the Chairman of SP is going to stop inviting Jim Vincent over for tea because of this. $10MM is a drop in the bucket and more money probably is owed. This is business, To.